In our study CTRP3 proved to be positively associated with DM biomarkers (FBG, HbA1c%, HOMA-IR and T2D duration) and negatively associated with QUICKI and MCP-1/CCL2 indicating its strong clinical association with the development of T2D. The gene discussed is CCL2; the disease is type 2 diabetes mellitus.